JPWO2021171003A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021171003A5 JPWO2021171003A5 JP2022550813A JP2022550813A JPWO2021171003A5 JP WO2021171003 A5 JPWO2021171003 A5 JP WO2021171003A5 JP 2022550813 A JP2022550813 A JP 2022550813A JP 2022550813 A JP2022550813 A JP 2022550813A JP WO2021171003 A5 JPWO2021171003 A5 JP WO2021171003A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- optionally
- sequence
- lcdr1
- lcdr2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2002581.3A GB202002581D0 (en) | 2020-02-24 | 2020-02-24 | Novel antibodies |
| GB2002581.3 | 2020-02-24 | ||
| PCT/GB2021/050460 WO2021171003A1 (en) | 2020-02-24 | 2021-02-24 | Ex vivo gamma delta t cell populations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023514437A JP2023514437A (ja) | 2023-04-05 |
| JPWO2021171003A5 true JPWO2021171003A5 (https=) | 2024-01-30 |
| JP2023514437A5 JP2023514437A5 (https=) | 2024-01-30 |
Family
ID=70108379
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550778A Pending JP2023516925A (ja) | 2020-02-24 | 2021-02-24 | 新規の抗体 |
| JP2022550813A Pending JP2023514437A (ja) | 2020-02-24 | 2021-02-24 | Ｅｘ ｖｉｖｏガンマデルタｔ細胞集団 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550778A Pending JP2023516925A (ja) | 2020-02-24 | 2021-02-24 | 新規の抗体 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20230159638A1 (https=) |
| EP (3) | EP4591882A3 (https=) |
| JP (2) | JP2023516925A (https=) |
| KR (2) | KR20220145894A (https=) |
| CN (2) | CN115697401A (https=) |
| AU (2) | AU2021228266A1 (https=) |
| BR (2) | BR112022016894A2 (https=) |
| CA (2) | CA3168973A1 (https=) |
| CL (1) | CL2022002296A1 (https=) |
| CO (2) | CO2022013542A2 (https=) |
| EC (1) | ECSP22074030A (https=) |
| GB (1) | GB202002581D0 (https=) |
| IL (2) | IL295852A (https=) |
| MX (2) | MX2022010383A (https=) |
| PE (1) | PE20230438A1 (https=) |
| WO (2) | WO2021171002A1 (https=) |
| ZA (1) | ZA202209699B (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202006989D0 (en) * | 2020-05-12 | 2020-06-24 | Gammadelta Therapeutics Ltd | Methods for isolating gamma delta t cells |
| AU2022222299A1 (en) | 2021-02-17 | 2023-09-07 | F-Star Therapeutics Limited | Multispecific anti-tcr delta variable 1 antibodies |
| CN119080924B (zh) * | 2024-07-04 | 2025-02-25 | 上海交通大学医学院附属第九人民医院 | 一种单克隆免疫球蛋白及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016081518A2 (en) * | 2014-11-17 | 2016-05-26 | Adicet Bio, Inc. | Engineered gamma delta t-cells |
| AU2016274633B2 (en) * | 2015-06-09 | 2022-04-21 | Gammadelta Therapeutics Ltd | Methods for the production of TCR gamma delta+ T cells |
| EP3454870A4 (en) * | 2016-05-12 | 2020-03-04 | Adicet Bio Inc. | METHOD FOR SELECTIVE EXPANSION OF GAMMA DELTA T CELL POPULATIONS AND COMPOSITIONS THEREOF |
| GB201818243D0 (en) | 2018-11-08 | 2018-12-26 | Gammadelta Therapeutics Ltd | Methods for isolating and expanding cells |
| CA3145523A1 (en) * | 2019-08-16 | 2021-02-25 | GammaDelta Therapeutics Limited | Therapeutic uses of anti-tcr delta variable 1 antibodies |
-
2020
- 2020-02-24 GB GBGB2002581.3A patent/GB202002581D0/en not_active Ceased
-
2021
- 2021-02-24 EP EP25177102.8A patent/EP4591882A3/en active Pending
- 2021-02-24 PE PE2022001812A patent/PE20230438A1/es unknown
- 2021-02-24 WO PCT/GB2021/050459 patent/WO2021171002A1/en not_active Ceased
- 2021-02-24 AU AU2021228266A patent/AU2021228266A1/en active Pending
- 2021-02-24 WO PCT/GB2021/050460 patent/WO2021171003A1/en not_active Ceased
- 2021-02-24 JP JP2022550778A patent/JP2023516925A/ja active Pending
- 2021-02-24 AU AU2021225390A patent/AU2021225390A1/en active Pending
- 2021-02-24 KR KR1020227033455A patent/KR20220145894A/ko active Pending
- 2021-02-24 MX MX2022010383A patent/MX2022010383A/es unknown
- 2021-02-24 CN CN202180028136.1A patent/CN115697401A/zh active Pending
- 2021-02-24 CA CA3168973A patent/CA3168973A1/en active Pending
- 2021-02-24 EP EP21709757.5A patent/EP4110813A1/en active Pending
- 2021-02-24 MX MX2022010239A patent/MX2022010239A/es unknown
- 2021-02-24 KR KR1020227029501A patent/KR20220164473A/ko active Pending
- 2021-02-24 US US17/904,890 patent/US20230159638A1/en active Pending
- 2021-02-24 BR BR112022016894A patent/BR112022016894A2/pt unknown
- 2021-02-24 US US17/801,786 patent/US20230090901A1/en active Pending
- 2021-02-24 JP JP2022550813A patent/JP2023514437A/ja active Pending
- 2021-02-24 EP EP21709758.3A patent/EP4110387B1/en active Active
- 2021-02-24 BR BR112022016671A patent/BR112022016671A2/pt unknown
- 2021-02-24 CN CN202180030584.5A patent/CN115461369A/zh active Pending
- 2021-02-24 IL IL295852A patent/IL295852A/en unknown
- 2021-02-24 CA CA3172340A patent/CA3172340A1/en active Pending
- 2021-02-24 IL IL295696A patent/IL295696A/en unknown
-
2022
- 2022-08-23 CL CL2022002296A patent/CL2022002296A1/es unknown
- 2022-08-30 ZA ZA2022/09699A patent/ZA202209699B/en unknown
- 2022-09-21 CO CONC2022/0013542A patent/CO2022013542A2/es unknown
- 2022-09-22 CO CONC2022/0013633A patent/CO2022013633A2/es unknown
- 2022-09-22 EC ECSENADI202274030A patent/ECSP22074030A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020520665A5 (https=) | ||
| JP6650537B2 (ja) | 抗ｃｔｌａ−４抗体 | |
| JP2025060802A5 (https=) | ||
| US20240052046A1 (en) | Il2rbeta/common gamma chain antibodies | |
| AU2009224690B2 (en) | Agent for treating disease | |
| RU2375375C2 (ru) | Гуманизированное анти-cd4 антитело с иммунодепрессивными свойствами | |
| CN109563170B (zh) | 抗gitr抗体及其用途 | |
| JP2021516976A5 (https=) | ||
| RU99109034A (ru) | Реконструированное человеческое анти-нм 1.24 антитело | |
| RU2018145852A (ru) | Антитело против lag-3, его антигенсвязывающий фрагмент и их фармацевтическое применение | |
| CA2148712A1 (en) | Peripheralization of hematopoietic stem cells | |
| JP2004538331A (ja) | インサイチュ免疫法 | |
| CN104822704A (zh) | 针对分化簇3(cd3)的人源化的抗体 | |
| JPH07246091A (ja) | 高い細胞毒性を有するモノクロナール抗体をヒトｃｄ１６− 抗原に対して産生するハイブリドーマ細胞株の選択的製造方法、並びにこの様なモノクロナール抗体の使用下に二重特異性モノクロナール抗体及びヒト腫瘍を治療するためのｃｄ３０− ｈｒｓ− ３− 抗体の製造方法 | |
| JPH10182487A (ja) | 抗−腫瘍免疫誘導のための二−および三特異抗体 | |
| JP2022525377A (ja) | 抗ｂｃｍａキメラ抗原受容体 | |
| JP2021500916A5 (https=) | ||
| HK1213782A1 (zh) | 在诊断和治疗类风湿性关节炎中使用的包含抗-cd6单克隆抗体的药物组合物 | |
| WO2016089610A1 (en) | Bispecific antibody for cancer immunotherapy | |
| JPWO2021171003A5 (https=) | ||
| EP4703384A1 (en) | Bispecific antibody targeting g protein-coupled receptor | |
| Te Wu et al. | Possible use of similar framework region amino acid sequences between human and mouse immunoglobulins for humanizing mouse antibodies | |
| JPWO2021171002A5 (https=) | ||
| CN106632673A (zh) | 抗pge2单克隆抗体及其使用 | |
| JPWO2021226085A5 (https=) |